KOSDAQ - Delayed Quote KRW

Aptamer Sciences Inc. (291650.KQ)

1,055.00

-17.00

(-1.59%)

At close: January 31 at 3:30:23 PM GMT+9

Aptamer Sciences Inc. Files IND Application for Innovative Liver Cancer Treatment AST-201: A Promising Approach to Address Under Medical Needs

Aptamer Sciences Inc. (KOSDAQ, 291650) announced the filing of an Investigational New Drug (IND) application for the phase 1 clinical trial of AST-201 with the Korean Ministry of Food and Drug Safety on March 12th, 2024.

PR Newswire 10 months ago

291650.KQ
-1.59%
291650.KS

Performance Overview

Return	291650.KQ	KOSPI Composite Index
YTD	-3.56%	+4.91%
1-Year	-64.72%	+0.81%
3-Year	-83.25%	-5.48%